FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA Compliance for Peptide Therapy and BPC 157 Holt Law This is one of the biggest peptide regulatory shifts in years. And it's just getting started. The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from HRT & Peptide Therapy: Energy, Weight Loss & Balance